The Biotech Stock Review has issued a new Report on Viral Genetics (VRAL), on the heels of an announcement that Professor Luc Montganier who won the Nobel Prize for Medicine, has joined Viral's Advisory Board.

While it is not unusual or uncommon to see a Nobel prize winner join the Board of a billion dollar Biotech Company or a Multi-National Pharmceutical giant -- how often, if ever have you seen that happen to a start-up Biotech Company -- which is selling for under $0.10 per share.

Now add to this the fact that Marshall Phelps Jr., the IP attorney (Intellectual Property & Strategy) for Microsoft has also joined the Company's Business Advisory Board (see news) it makes you wonder...what...along with the team of Harvard researchers, have they been working so feverishly on ?

What do these to individuals (including Dr. C Everett Koop) see that most investors don't ?

Send us an email to recieve updates on Viral Genetics: "Viral Updates"

2009 Report @ $0.06

2008 Report @ $0.01

Human Genome Sciences (HGSI) Interview


MannKind (MKND) on CNBC

Fox Video On HemoBiotech (HMBT).